We are live on
!
Find out more
SI
Scharf Investments Portfolio holdings
AUM
$3.03B
1-Year Est. Return
7.75%
This Fund
S&P 500
This Quarter
Est. Return
-9.17%
1 Year Est. Return
+7.75%
3 Year Est. Return
+55.03%
5 Year Est. Return
+80.17%
10 Year Est. Return
+289.59%
AUM
$2.93B
AUM Growth
-$441M
(-13%)
Cap. Flow
-$112M
Cap. Flow
% of AUM
-3.81%
Top 10 Holdings %
Top 10 Hldgs %
57.8%
Holding
51
New
2
Increased
4
Reduced
43
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$63M |
| 2 |
Booking.com
BKNG
|
+$27.4M |
| 3 |
MillerKnoll
MLKN
|
+$8.47M |
| 4 |
Baidu
BIDU
|
+$168K |
| 5 |
B
Barrick Mining
B
|
+$157K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$62.6M |
| 2 |
McKesson
MCK
|
+$44M |
| 3 |
Masco
MAS
|
+$36.6M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$13.9M |
| 5 |
Microsoft
MSFT
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.27% |
| 2 | Technology | 20.43% |
| 3 | Consumer Discretionary | 13.39% |
| 4 | Financials | 12.25% |
| 5 | Industrials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
McKesson
MCK
$104B
| $230M | 7.83% |
703,904
-137,501
| -16% | -$44M |
|
|
2
Microsoft
MSFT
$2.9T
| $212M | 7.24% |
826,340
-41,740
| -5% | -$11.3M |
|
3
Berkshire Hathaway Class B
BRK.B
$1.1T
| $198M | 6.76% |
725,274
-33,054
| -4% | -$10.4M |
|
4
CVS Health
CVS
$135B
| $176M | 6.01% |
1,900,112
-32,740
| -2% | -$3.2M |
|
5
Centene
CNC
$30.5B
| $168M | 5.72% |
1,982,341
-25,617
| -1% | -$2.13M |
|
6
Markel Group
MKL
$25.2B
| $158M | 5.39% |
122,064
-2,901
| -2% | -$3.98M |
|
7
Lockheed Martin
LMT
$131B
| $150M | 5.13% |
349,972
-6,301
| -2% | -$2.77M |
|
8
Advance Auto Parts
AAP
$3.53B
| $142M | 4.86% |
822,316
-9,041
| -1% | -$1.79M |
|
9
Oracle
ORCL
$339B
| $131M | 4.47% |
1,875,436
-14,617
| -0.8% | -$1.07M |
|
10
Johnson & Johnson
JNJ
$640B
| $129M | 4.39% |
724,244
-12,289
| -2% | -$2.19M |
|
11
Valvoline
VVV
$5.06B
| $126M | 4.29% |
4,364,879
-51,126
| -1% | -$1.57M |
|
12
Comcast
CMCSA
$87.3B
| $121M | 4.14% |
3,088,827
-18,989
| -0.6% | -$814K |
|
13
Novartis
NVS
$302B
| $112M | 3.81% |
1,322,606
-18,074
| -1% | -$1.59M |
|
|
14
MillerKnoll
MLKN
$1.56B
| $97.8M | 3.34% |
3,720,988
+279,608
| +8% | +$8.47M |
|
15
Cognizant
CTSH
$25.2B
| $94.4M | 3.22% |
1,398,604
-24,293
| -2% | -$1.86M |
|
16
Liberty Broadband Class C
LBRDK
$4.89B
| $92.1M | 3.14% |
796,668
-12,479
| -2% | -$1.52M |
|
|
FISV
17
Fiserv Inc
FISV
$29.7B
| $87.8M | 2.99% |
986,482
-142,931
| -13% | -$13.9M |
|
18
Constellation Brands
STZ
$22.5B
| $82.2M | 2.81% |
352,893
-2,732
| -0.8% | -$665K |
|
19
Unilever
UL
$142B
| $76.7M | 2.62% |
1,487,446
-7,718
| -0.5% | -$393K |
|
|
20
Masco
MAS
$14.3B
| $76.5M | 2.61% |
1,512,755
-692,847
| -31% | -$36.6M |
|
21
Canadian Pacific Kansas City
CP
$81B
| $71.6M | 2.44% |
1,025,388
-19,075
| -2% | -$1.38M |
|
|
ATVI
22
DELISTED
Activision Blizzard
ATVI
| $63.1M | 2.15% |
+809,937
| New | +$63M |
|
|
23
Baidu
BIDU
$35.7B
| $60.4M | 2.06% |
406,343
+1,271
| +0.3% | +$168K |
|
|
24
Booking.com
BKNG
$156B
| $22.4M | 0.77% |
+320,825
| New | +$27.4M |
|
25
State Street SPDR S&P 500 ETF Trust
SPY
$771B
| $15M | 0.51% |
39,792
-7,173
| -15% | -$2.94M |
|
Similar funds
MCM
CM
JIC
MB
CFM
SM
TAM
KIA
Scharf Investments's Q2 2022 Portfolio in Review
As of Q2 2022, Scharf Investments held 51 positions worth $2.93B, down 13% from $3.37B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Scharf Investments withdrew a net $112M in Q2 2022, closing 2 positions and reducing 43 holdings. Its most notable exit was iShares Russell 1000 ETF, an estimated $217K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Scharf Investments opened a new position in Activision Blizzard worth $63.1M.
- Scharf Investments's largest Q2 2022 buy was Activision Blizzard: 809,937 shares worth $63.1M.
- Scharf Investments added most to MillerKnoll in Q2 2022, an estimated $8.47M increase.
- Scharf Investments's biggest Q2 2022 reduction was AstraZeneca, cutting an estimated $62.6M.
- Scharf Investments fully exited iShares Russell 1000 ETF in Q2 2022, selling an estimated $217K.
- Scharf Investments's ten largest holdings make up 58% of its $2.93B portfolio in Q2 2022.
- Scharf Investments opened 2 new positions and closed 2 in Q2 2022.
- Scharf Investments's portfolio value fell 13% quarter-over-quarter to $2.93B.
Based on Scharf Investments's 13F filing for Q2 2022, filed 19 Jul 2022.